Cookies: Information & Consent

We have placed cookies on your device to help make this website better. Some of the cookies we use are essential for this site to work. We also use some non-essential cookies to collect information for making reports and to help us improve the site. You will find more detailled information in our Privacy Chart.

May 2018

Webinar : Advances in cardiovascular diagnostic devices for clinical trial

Tuesday, May 29th, 2018  6:00 PM CEST (Central European Time) UTC/GMT + 2…
Read the full post
April 2017

Event Participation 2017

Banook Group will attend the following exhibitions. Let’s meet there!
Read the full post
February 2017

Cardiabase by Banook Group opens subsidiary in Montreal, Canada

Group strengthens its presence in North American market, aiming for 30% growth in…
Read the full post
March 2015

Banook Group - New branding announcement

Cardiabase/Banook Central Imaging becomes Banook Group - New branding announcement.
Read the full post
March 2014

Webinar: Imaging anti-cancer treatment response at a preclinical and clinical stage

Use of imaging in oncology clinical trials is mainly based on morphological evaluation…
Read the full post
Mission & strategy > Our governance > Scientific board

Our governance

For each level of our governance, the key words are strong experience and motivation to further research and knowledge.

Scientific board

Pr. Olivier Lucidarme

Olivier Lucidarme is a Professor of Radiology at Pierre and Marie Curie University (UPMC-Paris VI). Since 1993 he has held a position as a radiologist specialized in oncologic imaging and abdominal imaging at la Pitié Salpêtrière hospital in Paris. Pr Lucidarme earned his PhD degree in 2003 for his research on functional imaging of angiogenesis performed at UPMC and the research imaging lab at the Hillcrest Hospital in San Diego (University of San Diego-California, USA).
Pr Lucidarme is currently in charge of oncologic imaging using CT, MRI, Ultrasound and contrast enhanced Ultrasound in clinical practice. He is particularly involved in clinical research concerning the assessment of tumor response using morphologic or functional imaging. He is also involved in translational research in angiogenesis imaging particularly using dynamic contrast enhanced ultrasound or MRI (Functional imaging lab, INSERM unit 678). Pr Lucidarme is a member of the International Cancer Imaging Society, European Society of Radiology, Radiological Society of North America and the European Society of Gastrointestinal and Abdominal Radiology.

Pr. Jean-Charles Soria

Jean-Charles Soria is a Professor of Medicine and Medical Oncology at South-Paris University. He is a tenure-track and full time cancer specialist at Institut Gustave Roussy (IGR). Dr Soria trained as a medical oncologist and obtained the Silver Medal from Paris Medical School in 1997. He gained a PhD degree in the fundamental basis of oncogenesis in 2001 and completed his training with a two-year post-doctoral fellowship in the Department of Thoracic Head and Neck Medical Oncology at MD Anderson Cancer Center, Houston, TX.
Pr Soria is currently Head of the Phase I Program at Institut Gustave Roussy and is a member of the lung cancer unit with a focus on targeted therapies. His main research interests are: early clinical development, phase I trials across solid tumors, pharmacodynamic biomarkers and lung cancer. He is also involved in translational research aspects related to tumor progression notably in lung cancer models (INSERM unit 981). Dr Soria was a member of ESMO executive committee from 2008 to 2009, and serves as an ASCO committee member since 2006. He has contributed to over 230 peer-reviewed publications, including publications as first or last author in the New England Journal of Medicine, the Journal of the National Cancer Institute, and the Journal of Clinical Oncology.

Pr Daniel O Slosman

Professor Daniel O Slosman, MD, joins BANOOK Central Imaging as scientific advisor in 2013.


Dr. Slosman received a Doctor of Medicine degree from the Geneva University Medical School, Geneva, (Switzerland) in 1982. His initial training in radio-oncology and nuclear medicine was completed at Brookhaven National Laboratory,Upton, NY (USA) as well as at the Columbia Presbyterian Hospital, College of Physicians and Surgeons of Columbia University, New York, (USA). After completion of his training in Nuclear Medicine, Dr. Slosman remained on the staff at the Geneva University Hospital. In 1997, he became professor and chief of Nuclear Medicine at the Geneva University Hospital.

During his work at the Geneva University Hospital, Prof. Slosman developed a great deal of interest on quality management and quality systems, bone density and osteoporosis, body composition as well as metabolic PET imaging. He had in charge the entire DXA QC program of the Ranelate of Strontium development including phase 3 FIRST-SOTI-TROPOS. He was also the coauthor a national program of research on neuroscience « PNR-38 Neuroscience » on Brain energy metabolism in dementias of the Alzheimer type.

Since moving in private clinical activity, he added additionnal expertise on bone metabolic disease, and dedicated part of his time on quality management, first being medical director for Nuclear Medicine at Synarc before joigning Banook Central Imaging.